المؤلفون: Santo R. Cortina, R. J. Griffiths, Marcie L. Vaughn-Bowser, Arturo Lopez-Anaya, Lori L. Lopresti-Morrow, Kim F. McClure, Kathleen M. Donahue, Shunda M. McGahee, Mary E. Lame, Christopher S. Jones, James D. Eskra, Ralph P. Robinson, Ivan G. Otterness, Jennifer L. Liras, Matthew R. Reese, Lisa M. Tobiassen, Sue A. Yocum, Gary J. Martinelli, Peter G. Mitchell, Lawrence A. Reiter, Marcia L. Bliven

المصدر: Bioorganic & Medicinal Chemistry Letters. 14:3389-3395

مصطلحات موضوعية: Matrix metalloproteinase inhibitor, Stereochemistry, Clinical Biochemistry, Pharmaceutical Science, Matrix Metalloproteinase Inhibitors, Hydroxamic Acids, Biochemistry, Chemical synthesis, Structure-Activity Relationship, chemistry.chemical_compound, Matrix Metalloproteinase 13, Drug Discovery, Humans, Structure–activity relationship, Protease Inhibitors, Molecular Biology, Pyrans, chemistry.chemical_classification, Sulfonamides, Hydroxamic acid, integumentary system, biology, Bicyclic molecule, Chemistry, Organic Chemistry, Matrix Metalloproteinases, Sulfonamide, Pyran, Enzyme inhibitor, Hepatocytes, biology.protein, Molecular Medicine, Matrix Metalloproteinase 1

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cbf1b568cb8f74bdeb9c13de17634182
https://doi.org/10.1016/j.bmcl.2004.04.083